Dr Reddys Laboratories (RDY) Profit After Tax Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) Profit After Tax Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 51.23% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -70.53% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -17.90% |
| 10 | Dr Reddys Laboratories | 9.84 Bn | 9.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 17.80% |
| Mar 31, 2023 | 29.61% |
| Sep 30, 2022 | -98.69% |
| Jun 30, 2021 | 26.63% |
| Mar 31, 2021 | 6.92% |
| Sep 30, 2020 | -51.42% |
| Sep 30, 2019 | -7.53% |
| Mar 31, 2019 | 7.95% |
| Dec 31, 2018 | -0.52% |
| Sep 30, 2018 | -6.99% |
| Jun 30, 2018 | -15.66% |
| Dec 31, 2017 | -17.02% |
| Sep 30, 2017 | -18.53% |
| Dec 31, 2016 | -38.59% |
| Sep 30, 2016 | -22.11% |
| Mar 31, 2016 | 15.09% |
| Dec 31, 2015 | -15.21% |
| Sep 30, 2015 | -2.20% |
| Jun 30, 2015 | -70.00% |
| Dec 31, 2014 | -71.78% |